Form D Explorer

Inspect source fieldsReport a record issue

Form D — Verrica Pharmaceuticals Inc.

0001231919-25-000594 · filed Dec 10, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$50,017,383
Reported amount sold
$50,017,383
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Verrica Pharmaceuticals Inc.
CIK
1660334
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
44 W. Gay St., Suite 400
WEST CHESTER, Pennsylvania 19380
Phone
484-453-3300

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗